Skip to content
Clinical Trial Events
19th Clinical Trials on Alzheimer's Disease (CTAD) 2026

Talk

Oral Communications

Tue, Nov 17, 2026 · 1:35–2:35 PM EST Ballroom - 4th floor, Boston Marriott Copley Place

About this session

Oral communications: OC11 A Unified Timeline of Alzheimer's Disease: Linking Amyloid-β to Cognitive Decline; OC12 When Plasma ptau217 and AβPET Disagree: Factors Associated With Biomarker Concordance and Discordance Across Ethnoracial Groups; OC13 Lecanemab Treatment in Real-World Settings Across Multiple Countries: A Meta-Analysis on ARIA Rates and Safety Profiles in Clinical Practice; OC14 Detecting cognitive decline in preclinical AD over 1.5 years using digital cognitive assessments.

Speakers

  • Susan Landau

    Research Neuroscientist · Helen Wills Neuroscience Institute, University of California, Berkeley

    Chair

  • Lefkos Middleton

    Imperial College London

    Chair